ARTICLE | Targets & Mechanisms
ASIRTaining a Parkinson's disease target
September 20, 2012 7:00 AM UTC
A Tufts University team has compelling evidence that reducing sirtuin 2
activity could be beneficial in Parkinson's disease.1 The findings argue for developing brain-penetrating sirtuin 2 inhibitors...